S&P Global and CME Group have finalized the sale of their joint venture, OSTTRA, to the global investment firm KKR for a total enterprise value of $3.1 billion. The proceeds from the sale will be split evenly between S&P Global and CME Group, as OSTTRA was a 50/50 joint venture. Established in 2021, OSTTRA offers a range of post-trade services and solutions for interest rates, foreign exchange, credit, and equity asset classes to the global financial ecosystem.
S&P Global and CME Group Complete $3.1 Billion Sale of OSTTRA to KKR
SPGI
Related News
SPGI
S&P Global Taps BCG Veteran to Finalize Mobility Leadership Ahead of 2026 Spin-Off
SPGI
S&P Global Shares Face Headwinds Following Guidance Miss and Target Cuts
SPGI
S&P Global Stabilizes After Post-Earnings Selloff; Stock Recovers 4.5% From February 10 Lows
SPGI
S&P Global Shares Recover as Analysts Defend Long-Term Outlook
SPGI